Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Acute transverse myelitis excluding MS, NMOSD and MOGAD: A 15-year real-world cohort from Iran.
Neuromyelitis optica presenting with mammillary body and cervicomedullary lesions after severe hyponatremia mimicking osmotic demyelination syndrome.
The Neurovascular Niche: A Gathering Venue for Neuroinflammation and Remyelination in Multiple Sclerosis.
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
Incidence and prevalence of small fibre neuropathy in the Netherlands: a multiple system estimation study.
TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis.
The effect of progressive muscle relaxation on intimacy and sexuality in women with multiple sclerosis: A single-blinded randomized controlled trial.
Financial Toxicity in Neuromyelitis Optica Spectrum Disorder: An ABC-X Mixed-Methods Study.
UNEXPECTED MECHANISMS OF REPURPOSED DRUGS IN THE PATHOGENIC PATHWAYS OF NEURODEGENERATIVE DISEASES. DISCOVERING NEW NEUROPROTECTIVE THERAPIES IN CELLULAR MODELS.
Investigating Disordered Eating Behaviours Among Individuals Living With Neurodegenerative Disease: A Scoping Review.
Investigation into the metabolomic effects of the non-canonical amino acid azetidine-2-carboxylic acid in neuroblastoma cells.
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.
Pde4 mediates MHCII expression in oligodendroglia.
Sexual dimorphism in the colonic microbiome and host's transcriptomics profiles of a murine model of multiple sclerosis.
Nasal-Predominant Ganglion Cell-Inner Plexiform Layer Thinning Distinguishes Early-Stage Leber Hereditary Optic Neuropathy From Acute Optic Neuritis.
GABAB receptors in glial cells: from physiological regulation to pathological implications.
C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications.
Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination.
Dyadic coping and multiple sclerosis: A qualitative exploration of differences between couples high and low in relationship functioning.
Genetic Prognostic Factors in Multiple Sclerosis: Key Discoveries and Unmet Needs.
Interleukin-40 and Soluble CD40 Ligand in Multiple Sclerosis: Inflammatory Signals or Clinically Applicable Biomarkers?
Biomimetic Microfibers for Myelin-Enhancer Screening and Neural Regeneration.
Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023.
Neurodegenerative Diseases in Children: A Comprehensive Review.
[Moxibustion promotes hematoma clearance in rats with intracerebral hemorrhage by up-regulating the expressions of PPARγ/CD36 and M2 phenotype polarization of microglia].
Pages
« first
‹ previous
…
994
995
996
997
998
999
1000
1001
1002
…
next ›
last »